Amphastar Pharmaceuticals, Inc. (AMPH) stock
AMPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3033% below fair value
$28.60−0.46 (-1.58%)
Close on Nov 11, 2026Market cap $1.22BP/E 13.0Yield –
Amphastar Pharmaceuticals EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Amphastar Pharmaceuticals's EV/EBITDA was 13.5× on Nov 11, 2026, against 10.8× a year earlier. Over the last 5 years it ranged from 7.0× to 21.2×, with a median of 11.5×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 13.5× | +3.0 |
| 2025 | Dec 31, 2025 | 10.5× | +2.3 |
| 2024 | Dec 31, 2024 | 8.2× | −8.3 |
| 2023 | Dec 29, 2023 | 16.5× | +4.7 |
| 2022 | Dec 30, 2022 | 11.9× | −6.6 |
| 2021 | Dec 31, 2021 | 18.4× | −39.2 |
| 2020 | Dec 31, 2020 | 57.6× | −456.5 |
| 2019 | Dec 31, 2019 | 514.1× | +339.3 |
| 2017 | Oct 31, 2017 | 174.8× | +150.9 |
| 2016 | Dec 30, 2016 | 23.8× | −0.7 |
| 2014 | Jul 31, 2014 | 24.5× | – |
See a number that looks wrong?